BioXcel Therapeutics, Inc. Restructuring Reserve, Current
BioXcel Therapeutics, Inc. (BTAI) had Restructuring Reserve, Current of $0 as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2026-03-27
- 2025-09-30: Restructuring Reserve, Current $0.00.
- 2025-06-30: Restructuring Reserve, Current $0.00.
- 2025-03-31: Restructuring Reserve, Current $128.00K.
- 2024-12-31: Restructuring Reserve, Current $603.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 |
| 2025-03-31 | $128.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $603.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.55M 10-Q · filed 2024-11-14 |
| 2024-09-17 | $1.55M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $3.91M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |